Samuel Amo Tobin, Chairman of the Tobinco Group has revealed that production of
Hydroxychloroquine & azithromycin two main treatment drugs for coronavirus will commence in end of May.
Produced by Entrance Pharmaceuticals &
Research Centre, a member of the Tobinco Group of Companies, to the Ghanaian market by June 2020.
A partnership between Tobinco & its Indian counterparts facilitated,
Ghanaian top pharmaceutical firm would not have had the privilege of importing the ingredients.
Only Indian has the permission to export the ingredient & a few companies outside.
